vs
Cronos Group Inc.（CRON）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是Cronos Group Inc.的1.3倍（$57.1M vs $44.5M），REGIS CORP净利率更高（0.8% vs -4.1%，领先4.9%），Cronos Group Inc.同比增速更快（47.0% vs 22.3%），Cronos Group Inc.自由现金流更多（$9.7M vs $891.0K），过去两年Cronos Group Inc.的营收复合增速更高（32.7% vs 7.8%）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
CRON vs RGS — 直观对比
营收规模更大
RGS
是对方的1.3倍
$44.5M
营收增速更快
CRON
高出24.7%
22.3%
净利率更高
RGS
高出4.9%
-4.1%
自由现金流更多
CRON
多$8.8M
$891.0K
两年增速更快
CRON
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $57.1M |
| 净利润 | $-1.8M | $456.0K |
| 毛利率 | 36.4% | — |
| 营业利润率 | -16.8% | 10.8% |
| 净利率 | -4.1% | 0.8% |
| 营收同比 | 47.0% | 22.3% |
| 净利润同比 | -104.2% | -94.0% |
| 每股收益（稀释后） | $-0.01 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONRGS
| Q4 25 | $44.5M | $57.1M | ||
| Q3 25 | $36.3M | $59.0M | ||
| Q2 25 | $33.5M | $60.4M | ||
| Q1 25 | $32.3M | $57.0M | ||
| Q4 24 | $30.3M | $46.7M | ||
| Q3 24 | $34.3M | $46.1M | ||
| Q2 24 | $27.8M | $49.4M | ||
| Q1 24 | $25.3M | $49.2M |
净利润CRONRGS
| Q4 25 | $-1.8M | $456.0K | ||
| Q3 25 | $26.0M | $1.4M | ||
| Q2 25 | $-39.7M | $116.5M | ||
| Q1 25 | $6.1M | $250.0K | ||
| Q4 24 | $43.7M | $7.6M | ||
| Q3 24 | $8.3M | $-853.0K | ||
| Q2 24 | $-8.8M | $91.2M | ||
| Q1 24 | $-2.2M | $-2.3M |
毛利率CRONRGS
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
营业利润率CRONRGS
| Q4 25 | -16.8% | 10.8% | ||
| Q3 25 | -1.4% | 10.0% | ||
| Q2 25 | -15.9% | 12.1% | ||
| Q1 25 | -12.6% | 8.8% | ||
| Q4 24 | -37.5% | 11.8% | ||
| Q3 24 | -98.2% | 4.6% | ||
| Q2 24 | -56.1% | — | ||
| Q1 24 | -63.1% | 8.3% |
净利率CRONRGS
| Q4 25 | -4.1% | 0.8% | ||
| Q3 25 | 71.4% | 2.3% | ||
| Q2 25 | -118.7% | 192.9% | ||
| Q1 25 | 19.0% | 0.4% | ||
| Q4 24 | 144.3% | 16.4% | ||
| Q3 24 | 24.4% | -1.9% | ||
| Q2 24 | -31.5% | 184.7% | ||
| Q1 24 | -8.9% | -4.7% |
每股收益（稀释后）CRONRGS
| Q4 25 | $-0.01 | $0.16 | ||
| Q3 25 | $0.07 | $0.49 | ||
| Q2 25 | $-0.10 | $43.67 | ||
| Q1 25 | $0.02 | $0.08 | ||
| Q4 24 | $0.12 | $2.71 | ||
| Q3 24 | $0.02 | $-0.36 | ||
| Q2 24 | $-0.02 | $38.40 | ||
| Q1 24 | $-0.01 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $1.1B | $188.7M |
| 总资产 | $1.2B | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资CRONRGS
| Q4 25 | $831.8M | $18.4M | ||
| Q3 25 | $824.2M | $16.6M | ||
| Q2 25 | $834.4M | $17.0M | ||
| Q1 25 | $837.8M | $13.3M | ||
| Q4 24 | $858.8M | $10.2M | ||
| Q3 24 | $862.0M | $6.3M | ||
| Q2 24 | $848.2M | $10.1M | ||
| Q1 24 | $855.1M | $5.9M |
总债务CRONRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益CRONRGS
| Q4 25 | $1.1B | $188.7M | ||
| Q3 25 | $1.1B | $187.6M | ||
| Q2 25 | $1.1B | $185.6M | ||
| Q1 25 | $1.1B | $68.6M | ||
| Q4 24 | $1.1B | $66.7M | ||
| Q3 24 | $1.1B | $56.4M | ||
| Q2 24 | $1.1B | $56.8M | ||
| Q1 24 | $1.1B | $-35.8M |
总资产CRONRGS
| Q4 25 | $1.2B | $588.3M | ||
| Q3 25 | $1.2B | $592.1M | ||
| Q2 25 | $1.2B | $599.0M | ||
| Q1 25 | $1.2B | $511.2M | ||
| Q4 24 | $1.2B | $530.1M | ||
| Q3 24 | $1.2B | $508.9M | ||
| Q2 24 | $1.1B | $530.5M | ||
| Q1 24 | $1.1B | $543.7M |
负债/权益比CRONRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $891.0K |
| 自由现金流率自由现金流/营收 | 21.8% | 1.6% |
| 资本支出强度资本支出/营收 | 4.8% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $149.0K | $14.9M |
8季度趋势，按日历期对齐
经营现金流CRONRGS
| Q4 25 | $11.8M | $1.7M | ||
| Q3 25 | $13.3M | $2.3M | ||
| Q2 25 | $2.8M | $6.8M | ||
| Q1 25 | $-2.1M | $6.2M | ||
| Q4 24 | $7.7M | $2.1M | ||
| Q3 24 | $11.6M | $-1.3M | ||
| Q2 24 | $1.7M | $5.1M | ||
| Q1 24 | $-2.2M | $-277.0K |
自由现金流CRONRGS
| Q4 25 | $9.7M | $891.0K | ||
| Q3 25 | $8.8M | $1.9M | ||
| Q2 25 | $-1.0M | $6.2M | ||
| Q1 25 | $-17.4M | $5.9M | ||
| Q4 24 | $4.2M | $1.7M | ||
| Q3 24 | $5.2M | $-1.4M | ||
| Q2 24 | $1.0M | $5.1M | ||
| Q1 24 | $-3.9M | $-326.0K |
自由现金流率CRONRGS
| Q4 25 | 21.8% | 1.6% | ||
| Q3 25 | 24.3% | 3.2% | ||
| Q2 25 | -3.0% | 10.3% | ||
| Q1 25 | -53.8% | 10.3% | ||
| Q4 24 | 13.8% | 3.6% | ||
| Q3 24 | 15.1% | -3.0% | ||
| Q2 24 | 3.7% | 10.3% | ||
| Q1 24 | -15.5% | -0.7% |
资本支出强度CRONRGS
| Q4 25 | 4.8% | 1.4% | ||
| Q3 25 | 12.3% | 0.7% | ||
| Q2 25 | 11.5% | 0.9% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 0.9% | ||
| Q3 24 | 18.7% | 0.0% | ||
| Q2 24 | 2.6% | 0.0% | ||
| Q1 24 | 6.8% | 0.1% |
现金转化率CRONRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 0.51× | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | -0.34× | 24.80× | ||
| Q4 24 | 0.18× | 0.28× | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
